After Emergent COVID-19 Manufacturing Mess, J&J Team Takes Charge

Earlier last week, Emergent BioSolutions’ production facility in Baltimore botched production for an ingredient for Johnson & Johnson’s COVID-19 vaccine. J&J has a contract with Emergent for its production plant in Baltimore. The problem involved one batch of an ingredient in the vaccine. Now, J&J is taking over the production at that facility. In order to have full control of J&J’s product.
Read more...

;